LYNDSEY BURIAK: Open Payments
NPI 1629432034 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 57 payments from 25 companies in 2025. Trend: 2023 $948 · 2024 $978 · 2025 $1,241
Food & beverage: $1,241
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $259 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $161 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Exact Sciences Corporation | 3 | $68 |
| Lilly USA, LLC | 3 | $68 |
| Eisai Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $47 |
| TOLMAR, INC. | 3 | $47 |
Products named: XIFAXAN, Wegovy, TRELEGY ELLIPTA, Cologuard Collection Kit, MOUNJARO, Leqembi, REXULTI, Kerendia.
Industry payments across TX — which companies pay providers there.
